Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Terminated 2Withdrawn 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Melanoma 6Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Ovarian Cancer Metastatic 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Kidney Neoplasms 1Invasive Bladder Cancer Stage IV 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 8Azacitidine 8fludarabine phosphate 6fludarabine 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Methotrexate 5Cyclosporine 5Busulfan 5Decitabine 4Tacrolimus 3Mycophenolic Acid 3Filgrastim 3Cytarabine 3AP 1903 reagent 3venetoclax 2magrolimab 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Saline Solution 2Radiotherapy 2Nivolumab 2Cyclosporins 2Biopsy 2Alemtuzumab 2tumor-cells apoptosis factor, human 1sabatolimab 1ponatinib 1plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Myelodysplastic Syndromes × Interleukin-2 × Clear all
NCT04893915 2022-03-11

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Washington University School of Medicine

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡